Browsing Tag

AntiAmyloid

Acumen’s ACU193, an Anti-Amyloid Beta Oligomer Antibody, Granted FDA Fast Track Designation for…

Jason Junior Oct 24, 2022

CHARLOTTESVILLE, Va. and CARMEL, Ind., Oct. 24, 2022 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) today announced that ACU193, the first clinical-stage monoclonal antibody that selectively targets toxic soluble amyloid…

Health

Alzheimer‘s: Amyloid and tau are a perilous couple: Current findings give backing to Anti-Amyloid…

Jason Junior Mar 31, 2022

In the course of Alzheimer's disease, two proteins called "amyloid" and "tau" accumulate in the brain. A DZNE study with more than 200 participants now provides insights into the interaction of these pathological phenomena. The data suggest…